Outlook Therapeutics Non-GAAP EPS of -$0.16 misses by $0.04, revenue of $0.13M misses by $4.27M

3 Reasons to Sell WDAY and 1 Stock to Buy Instead

2026/08/09

Trump signals economic pressure over new Iran strikes as Hormuz talks stall

2026/08/09

Trustmark (TRMK): Buy, Sell, or Hold Post Q2 Earnings?

2026/08/09

3 Reasons PATH is Risky and 1 Stock to Buy Instead

2026/08/09